1-7 of 7
Andrew P. Mone
Close
Sort by
Journal Articles

Effects of the Redox Mediator Motexafin Gadolinium in a Pilot Phase I Trial in Refractory Chronic Lymphocytic Leukemia (CLL).

Thomas S. Lin, MD, PhD, Sabyasachi Biswas, PhD, Louie Naumovski, MD, PhD, Phillip Lecane, PhD, Margaret S. Lucas, PA-C, Mollie E. Moran, CRNP, Andrew P. Mone, MD, PhD, David M. Lucas, PhD, See-Chun Phan, MD, Richard A. Miller, MD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 3486.
https://doi.org/10.1182/blood.V104.11.3486.3486
Published: 2004
Journal Articles

Arsenic Trioxide and Ascorbic Acid Enhances the Cytotoxicity of Hu1D10 towards CLL Cells.

Sabyasachi Biswas, PhD, Andrew P. Mone, MD, PhD, Chandan K. Sen, PhD, Natarajan Muthusamy, PhD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 3479.
https://doi.org/10.1182/blood.V104.11.3479.3479
Published: 2004
Journal Articles

Leflunomide Inhibits Proliferation of Neoplastic B-Cell Lines and Induces Apoptosis in Primary CLL Cells.

Andrew P. Mone, MD PhD, John C. Byrd, MD
Journal: Blood
Blood (2004) 104 (11): 2497.
https://doi.org/10.1182/blood.V104.11.2497.2497
Published: 2004
Journal Articles

Alemtuzumab Induces Cell Death in Human Chronic Lymphocytic Leukemia Cells through a Lipid Raft-Dependent Mechanism.

Andrew P. Mone, Carolyn Cheney, Amy Banks, Sara Jefferson, Thomas Lin, Charles Eisenbeis, John C. Byrd
Journal: Blood
Blood (2004) 104 (11): 2507.
https://doi.org/10.1182/blood.V104.11.2507.2507
Published: 2004
Journal Articles

Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells

Andrew P. Mone, Peng Huang, Helene Pelicano, Carolyn M. Cheney, Jennifer M. Green, J. Yun Tso, Amy J. Johnson, Sara Jefferson, Thomas S. Lin, John C. Byrd
Journal: Blood
Blood (2004) 103 (5): 1846–1854.
https://doi.org/10.1182/blood-2003-08-2836
Published: 2004
Journal Articles

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8–mediated apoptosis and down-regulation of c-FLIP protein

Jennifer L. Aron, Mark R. Parthun, Guido Marcucci, Shinichi Kitada, Andrew P. Mone, Melanie E. Davis, Tiansheng Shen, Timothy Murphy, Joseph Wickham, Chris Kanakry, David M. Lucas, John C. Reed, Michael R. Grever, John C. Byrd
Journal: Blood
Blood (2003) 102 (2): 652–658.
https://doi.org/10.1182/blood-2002-12-3794
Published: 2003
Journal Articles

KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis

John C. Byrd, David M. Lucas, Andrew P. Mone, Joshua B. Kitner, Joseph J. Drabick, Michael R. Grever
Journal: Blood
Blood (2003) 101 (11): 4547–4550.
https://doi.org/10.1182/blood-2002-08-2623
Published: 2003